http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108299531-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-06 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H1-00 |
filingDate | 2018-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-108299531-B |
titleOfInvention | Methetavlosin pharmaceutical salt and preparation method thereof |
abstract | The invention belongs to the field of antibiotic synthesis, and particularly relates to a high-purity mepivacaine salt and a preparation method thereof. The method comprises the steps of taking tylosin tartrate, N-methylpiperazine and formic acid as raw materials, heating, refluxing, reacting, decoloring, adjusting the pH value with alkali, and performing suction filtration to obtain the methamphetamine. Heating and refluxing the metoclopramide and acid, and performing suction filtration to obtain the medicinal salt of the metoclopramide. The traditional Chinese medicine composition is used for treating swine mycoplasma infection, and has the advantages of definite curative effect, high bioavailability, small side effect, simple and convenient process operation and convenience for industrial production, and the cure rate reaches more than 96.0%. |
priorityDate | 2018-01-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 66.